Fujifilm Holdings Corporation

4901

JP3814000000

Specialty Chemicals

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-09 am EDT			5-day change	1st Jan Change
3,453 ^JPY	-0.06%		+1.17%	+22.26%

Apr. 26	FUJIFILM Holdings Corporation Introduces Transducer for On-Pump Intracardiac Echocardiography Imaging for Septal Myectomy	CI
Apr. 18	Tech Issue Revival Boosts Asian Stock Markets	MT

Fuji Film Holdings : Establishment of Fujifilm Kyowa Kirin Biologics — joint-venture of Fujifilm and Kyowa Hakko Kirin for the development, manufacturing and sales of biosimilars

March 27, 2012 at 02:14 am EDT

MarketScreener.com By

Joint-Venture of Fujifilm and Kyowa Hakko Kirin for the development, manufacturing and sales of biosimilars

March 27, 2012

FUJIFILM Corporation
Kyowa Hakko Kirin Co., Ltd.

FUJIFILM Corporation (President and CEO Shigetaka Komori; hereinafter "Fujifilm") and Kyowa Hakko Kirin Co., Ltd. (President and CEO Nobuo Hanai; hereinafter "Kyowa Hakko Kirin") commenced business operations of the "FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd." (President and CEO Hideaki Nomura; hereinafter "Fujifilm Kyowa Kirin Biologics"), a joint-venture for the development, manufacturing and sales of biosimilars.

Fujifilm Kyowa Kirin Biologics will merge Fujifilm's advanced production technology, quality control technology and analysis technology developed through its photographic film business over many years, with Kyowa Hakko Kirin's proprietary technologies and know-how, accumulated through its biopharmaceutical R&D and manufacturing, in order to create revolutionary production processes and to achieve cost reduction for biosimilars. The development and timely introduction of highly reliable, high-quality and cost-competitive biosimilars through this partnership will aim to obtain position as the market leader.

Fujifilm Kyowa Kirin Biologics will first focus on the development of the biosimilar of the fully human anti-TNF-

Latest news about Fujifilm Holdings Corporation

FUJIFILM Holdings Corporation Introduces Transducer for On-Pump Intracardiac Echocardiography Imaging for Septal Myectomy	Apr. 26	CI
Tech Issue Revival Boosts Asian Stock Markets	Apr. 18	MT
Fujifilm Raises Targets for Fiscal Year Ended March	Apr. 18	MT
FUJIFILM Holdings Corporation Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024	Apr. 17	CI
FUJIFILM Holdings Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2025 and Year Ending March 31, 2027	Apr. 17	CI
Konica Minolta, Fujifilm Sign Memorandum to Study Potential Joint Venture	Apr. 15	DJ
Global markets live: BP, Apple, Vodafone, Ford, Lockheed Martin...	Apr. 12
Fujifilm to Invest Additional $1.2 Billion In US-based Large-Scale Cell Culture CDMO Business	Apr. 11	MT
Fujifilm to invest $1.2 bln in North Carolina plant in biopharma expansion	Apr. 11	RE
Jefferies Adjusts Fujifilm Holdings’ Price Target to 4,000 Yen From 3,766 Yen, Keeps at Buy	Apr. 08	MT
Novavax Reports Settlement Agreement With Fujifilm	Mar. 26	MT
Jefferies Adjusts Fujifilm’s Price Target to 11,300 Yen From 10,500 Yen, Keeps at Buy	Feb. 28	MT
FUJIFILM Holdings Corporation's company FUJIFILM Healthcare Americas Corporation Receives PACS Award for Naval Medical Center - San Diego	Feb. 20	CI
Japanese Shares Cross 37,000 Mark on SoftBank Rally	Feb. 09	MT
Fujifilm's Nine-Month Attributable Net Income Jumps 13% on Higher Medical Systems, Imaging Sales	Feb. 08	MT
FUJIFILM Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08	CI
Bayer: exercises license option for vision loss	Jan. 23	CF
Fujifilm to Invest $200 Million to Expand Cell Therapy Development, Manufacturing Capabilities	Dec. 04	DJ
Fujifilm Corporation to Invest Usd 200 Million to Expand Cell Therapy Development and Manufacturing Capabilities	Dec. 04	CI
FUJIFILM Diosynth Biotechnologies California, Inc. announced that it has received funding from FUJIFILM Holdings Corporation	Dec. 03	CI
FUJIFILM Cellular Dynamics, Inc. announced that it has received funding from FUJIFILM Holdings Corporation	Dec. 03	CI
Siav goes up after being awarded four lots in Consip tender	Nov. 22	AN
National Grid Renewables Announces Power Purchase Agreements with Fujifilm and Bristol Myers Squibb	Nov. 16	CI
Japanese Shares Close Higher on Thursday, Buoyed by Corporate Earnings	Nov. 09	MT
Fujifilm's Fiscal H1 Attributable Net Income Rises on Higher Medical Systems, Imaging Sales	Nov. 08	MT

Chart Fujifilm Holdings Corporation

Duration

Period

More charts

Company Profile

Fujifilm Holdings Corporation specializes in the manufacturing and marketing of printing, imaging and photography materials and equipment. Net sales break down by activity as follows: - sale of printers and photocopiers (42.7%); - sale of medical imaging equipment (41.4%): digital endoscopes, digital mammography devices, radiologic tables, ultrasound scan systems, etc. The group also develops pharmaceutical products development (generic drugs, health products, etc.) and design of graphic arts materials activities; - sale of photography equipment (15.9%): digital cameras, bridges, lens, color negative films, films development materials, etc. Net sales are distributed geographically as follows: Japan (48.7%), Americas (18.7%), Europe (10.1%) and other (22.5%).

Sector

Specialty Chemicals

Calendar

2024-05-08 - Q4 2024 Earnings Release

Related indices

Nikkei 225

More about the company

Income Statement Evolution

More financial data

Ratings for Fujifilm Holdings Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3,455 JPY

Average target price

3,832 JPY

Spread / Average Target

+10.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
FUJIFILM HOLDINGS CORPORATION	+22.26%	26.74B
ECOLAB INC.	+17.59%	66.6B
SIKA AG	+0.84%	48.75B
GIVAUDAN SA	+17.11%	41.45B
EMS-CHEMIE HOLDING AG	+11.45%	19.55B
CELANESE CORPORATION	+5.08%	18.21B
POSCO FUTURE M CO., LTD.	-21.31%	16.02B
SYMRISE AG	+4.38%	15.62B
ALBEMARLE CORPORATION	-9.70%	15.33B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-20.79%	13.62B

Other Specialty Chemicals

Fujifilm Holdings Corporation

Equities

4901

JP3814000000

Specialty Chemicals

Fuji Film Holdings : Establishment of Fujifilm Kyowa Kirin Biologics — joint-venture of Fujifilm and Kyowa Hakko Kirin for the development, manufacturing and sales of biosimilars

EPS Revisions